Organogenesis Holdings Inc (ORGO) — Cash Flow-to-Debt Ratio
Organogenesis Holdings Inc (ORGO) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $3.08 Million could theoretically repay 0% of its total liabilities ($123.85 Million) in one year. Check total reinvestment intensity of Organogenesis Holdings Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Organogenesis Holdings Inc Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Organogenesis Holdings Inc across 11 annual periods. Also explore ORGO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Organogenesis Holdings Inc (2001–2024)
Year-by-year debt coverage analysis for Organogenesis Holdings Inc. For market capitalisation and broader financial context, see ORGO stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | $14.21 Million | $112.57 Million | ▼ -26.0% |
| 2023 | 0.17x | $30.92 Million | $181.36 Million | ▲ +26.0% |
| 2022 | 0.14x | $24.86 Million | $183.69 Million | ▼ -55.9% |
| 2021 | 0.31x | $61.98 Million | $201.92 Million | ▲ +733.4% |
| 2020 | 0.04x | $5.47 Million | $148.41 Million | ▲ +118.1% |
| 2019 | -0.20x | $-33.53 Million | $165.10 Million | ▲ +61.0% |
| 2018 | -0.52x | $-60.74 Million | $116.64 Million | ▼ -1212.0% |
| 2017 | -0.04x | $-586.60K | $14.78 Million | ▲ +20.0% |
| 2016 | -0.05x | $-562.23K | $11.33 Million | ▲ +99.8% |
| 2015 | -24.48x | $-10.19 Million | $416.43K | ▼ -8145.9% |
| 2001 | -0.30x | $-1.40 Million | $4.70 Million | — |